Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13701
Country/Region: Kenya
Year: 2014
Main Partner: Kenya Medical Supplies Agency
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: USAID
Total Funding: $36,274,080 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Kenya Medical Supplies Agency (KEMSA) is a customer-focused integrated medical logistics provider for all public health facilities in Kenya. As a State Corporation, KEMSA is a secure source of value-for-money drugs and other medical supplies to over 5,000 facilities. KEMSA has also received substantial TA and support from USAID in human resource capacity building through the deployment of key advisors in areas of business development, procurement, IT and supply chain management. With USAID support, KEMSA has invested in an effective Enterprise Resource Planning (ERP) system that has led to the full automation and integration of KEMSA operations and overall business processes, resulting in greater efficiency and improved service delivery. KEMSA's fully automated central warehouse in Nairobi is now functioning under the platform of a Warehouse Module System hosted by the ERP. This has significantly improved efficiency in inventory management and processing of health facilities requirements. KEMSA has successfully implemented the Framework Contract system, and all current procurements are aligned to KEMSA’s strategic and business plan with enhanced visibility of all health care commodities in the supply chain. Currently KEMSA has a total allocation of $60 million for essential medical supplies, approximately $85 million for programs such as HIV, malaria and tuberculosis. KEMSA has been appointed as the procurement agent for the GFATM R10 procurements, and the USG is confident that KEMSA is ready to start handling some PEPFAR commodities. The program develops a Performance Monitoring Plan (PMP) on a yearly basis which will be reviewed with the partner during quarterly meetings to ensure that targets are being met.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $17,450,000
Care: TB/HIV (HVTB) $1,752,139
Laboratory Infrastructure (HLAB) $1,400,000
Biomedical Prevention: Blood Safety (HMBL) $1,500,000
Biomedical Prevention: Injection Safety (HMIN) $350,000
Testing: HIV Testing and Counseling (HVCT) $6,172,541
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $2,662,000
Treatment: ARV Drugs (HTXD) $700,000
Treatment: Adult Treatment (HTXS) $2,376,688
Treatment: Pediatric Treatment (PDTX) $1,910,712
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

This mechanism has no published performance targets or indicators.